Antagonistic Peptides That Specifically Bind to the First and Second Extracellular Loops of CCR5 and Anti-IL-23p19 Antibody Reduce Airway Inflammation by Suppressing the IL-23/Th17 Signaling Pathway

Table 1

Correlation between the expression of the CCR5 and IL-23p19 proteins in the treatment groups ().

Treatment groups		value
Anti-IL-23p19 group	0.612	0.080
GH group	0.790	0.011
HY group	0.747	0.021
Anti-IL-23p19 with HY group	0.799	0.010